Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival | Zendy

Anthony Oyekunle | Zendy; M. A. Durosinmi | Zendy; Rahman A. Bolarinwa | Zendy; Temilola Owojuyigbe | Zendy; L Salawu | Zendy; Norah O. Akinola | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival

Author(s) -

Anthony Oyekunle,

M. A. Durosinmi,

Rahman A. Bolarinwa,

Temilola Owojuyigbe,

L Salawu,

Norah O. Akinola

Publication year - 2016

Publication title -

clinical medicine insights blood disorders

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.405

H-Index - 10

ISSN - 1179-545X

DOI - 10.4137/cmbd.s31562

Subject(s) - medicine , myeloid leukemia , imatinib , confidence interval , gastroenterology , odds ratio , anemia , proportional hazards model , multivariate analysis

The advent of the tyrosine kinase inhibitors has markedly changed the prognostic outlook for patients with Ph(+) and/or BCR-ABL1 (+) chronic myeloid leukemia (CML). This study was designed to assess the overall survival (OS) of Nigerian patients with CML receiving imatinib therapy and to identify the significant predictors of OS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research